These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23568997)

  • 1. Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Baird RA; Wiebe S; Zunt JR; Halperin JJ; Gronseth G; Roos KL
    Neurology; 2013 Apr; 80(15):1424-9. PubMed ID: 23568997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Sethi NK
    Neurology; 2013 Oct; 81(16):1475-6. PubMed ID: 24278969
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Gonzalez-Duarte A
    Neurology; 2013 Oct; 81(16):1474-5. PubMed ID: 24278968
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Burneo JG; Escalaya AL
    Neurology; 2013 Oct; 81(16):1474. PubMed ID: 24127192
    [No Abstract]   [Full Text] [Related]  

  • 5. Author response.
    Baird RA; Wiebe S; Zunt JR; Halperin JJ; Roos KL
    Neurology; 2013 Oct; 81(16):1475-6. PubMed ID: 24278970
    [No Abstract]   [Full Text] [Related]  

  • 6. Anthelmintics for people with neurocysticercosis.
    Abba K; Ramaratnam S; Ranganathan LN
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD000215. PubMed ID: 20238309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthelmintics for people with neurocysticercosis.
    Abba K; Ramaratnam S; Ranganathan LN
    Cochrane Database Syst Rev; 2010 Jan; (1):CD000215. PubMed ID: 20091504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
    Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis.
    Singhi P; Jain V; Khandelwal N
    J Child Neurol; 2004 May; 19(5):323-7. PubMed ID: 15224704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Drugs for treating neurocysticercosis (tapeworm infection of the brain).
    Salinas R; Prasad K
    Cochrane Database Syst Rev; 2007 Jul; (4):CD000215. PubMed ID: 17636621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating neurocysticercosis medically: a systematic review of randomized, controlled trials.
    Salinas R; Counsell C; Prasad K; Gelband H; Garner P
    Trop Med Int Health; 1999 Nov; 4(11):713-8. PubMed ID: 10588764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
    Del Brutto OH; Roos KL; Coffey CS; García HH
    Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
    Matthaiou DK; Panos G; Adamidi ES; Falagas ME
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e194. PubMed ID: 18335068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Bhidayasiri R; Fahn S; Weiner WJ; Gronseth GS; Sullivan KL; Zesiewicz TA;
    Neurology; 2013 Jul; 81(5):463-9. PubMed ID: 23897874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis.
    Santos IC; Kobayashi E; Cardoso TM; Guerreiro CA; Cendes F
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1014-20. PubMed ID: 11105066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for treating neurocysticercosis (tapeworm infection of the brain).
    Salinas R; Prasad K
    Cochrane Database Syst Rev; 2000; (2):CD000215. PubMed ID: 10796510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
    Garcia HH; Del Brutto OH;
    Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology.
    Zesiewicz TA; Elble RJ; Louis ED; Gronseth GS; Ondo WG; Dewey RB; Okun MS; Sullivan KL; Weiner WJ
    Neurology; 2011 Nov; 77(19):1752-5. PubMed ID: 22013182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Patwa HS; Chaudhry V; Katzberg H; Rae-Grant AD; So YT
    Neurology; 2012 Mar; 78(13):1009-15. PubMed ID: 22454268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
    Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I
    N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.